NIH-funded research R01 grant

A biomarker-based way to quantify visceral pain in IBS

Official title: Objective Integrated Multimodal Electrophysiological Index for the Quantification of Visceral Pain

Funded at University of Connecticut Storrs · NIH-11349721 · Data updated 2026-11-12

A new approach aims to measure visceral pain in IBS patients with an objective multimodal electrophysiological index to improve drug and non-drug treatments.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Connecticut Storrs
NIH-funded
Lab location1 site (Storrs-Mansfield, United States)
Project startAugust 1, 2024
Project endMay 31, 2029
Funding year2026
Award (this year)$598,364
NIH project number5R01DK138248-03
Project IDNIH-11349721 on NIH RePORTER

Who could benefit from this research

Could help

Adults diagnosed with irritable bowel syndrome experiencing visceral pain who can undergo electrophysiological measurements.

Less likely to help

Patients without IBS or those unable to participate in electrophysiological testing may not benefit.

What this research studies

This project seeks to create an objective biomarker by combining multiple electrophysiological signals to quantify visceral pain in people with IBS. By linking autonomic nervous system activity and abdominal muscle signals to pain levels, it hopes to reduce reliance on patient self-reports in trials. The goal is to help developers test treatments more efficiently and identify non-drug therapies that relieve IBS pain. If successful, the index could guide personalized pain management strategies for IBS patients. The work is conducted at the University of Connecticut with a focus on translating biomarkers into clinical trial endpoints.

Why it matters

Potential benefit: If successful, patients with IBS could receive faster-acting, more accurate pain management and better-tailored therapies.

How similar studies have gone: Previous work shows correlations between autonomic activity, muscle signals, and pain, but this specific integrated biomarker is novel.

Where this research is happening

  • University of Connecticut Storrs
    Storrs-Mansfield, United States
    Active

Researchers

  • Principal investigator: Posada-Quintero, Hugo Fernando — University of Connecticut Storrs
  • Study coordinator: Posada-Quintero, Hugo Fernando

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.